Kernal Biologics develops mRNA therapeutics designed for targeted delivery and selective translation, including in vivo CAR-T therapies for cancer and autoimmune diseases.
Kernal Biologics develops mRNA therapeutics designed for targeted delivery and selective translation, including in vivo CAR-T therapies for cancer and autoimmune diseases.